Self management of urinary symptoms after prostate cancer treatment

Phase 3

Completed

• Conditions: Prostate cancer; Cancer; Malignant neoplasm of prostate

• Registration Number: ISRCTN20069765
• Lead Sponsor: niversity of Surrey (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-03-13
• Study Completion: 2014-02-28
• Last Update Posted: 26 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 96

Inclusion Criteria

1. Men
2. Have locally contined prostate cancer up to stage T3BNO
3. Have received neoadjuvant hormonal therapy
4. Have completed radiotherapy three to four months prior to the intervention
5. Have urinary syptopms and an IPSS score of 8+
6. Have sufficient understanding of written and spoken English

Added 27/01/2014:
7. Brachytherapy patients

Exclusion Criteria

1. Have a urinary tract infection
2. Have a current psychiatric referral
3. Have a current referral for memory issues
4. Require an interpreter

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
rinary syptoms measured by the International Prostate Symptom Score (IPSS); Timepoint(s): At two months (end of intervention) and 6 months past baseline

Secondary Outcome Measures

Name	Time	Method
Quality of life measured by the EORTC 25, and emotional distress measured by the EORTC 30 ? both at 2 and 6 months post baseline.